Oxytocin
Oxytocin is an endogenous nonapeptide produced in the paraventricular and supraoptic nuclei of the hypothalamus, playing central roles in parturition, lactation, and the regulation of social behavior, trust, and bonding through central oxytocinergic projections. Intranasal administration is the primary delivery route for CNS-targeted effects, as the peptide does not readily cross the blood-brain barrier when given systemically. Clinical trials in autism spectrum disorder have shown inconsistent results — early promising data on social cognition have not been reliably replicated in larger or longer-term trials. Evidence in PTSD and social anxiety is preliminary, and the therapeutic window for cognitive and behavioral effects appears highly context- and dose-dependent; intranasal oxytocin can produce prosocial effects in some settings while increasing in-group/out-group discrimination in others.
Evidence last reviewed: 19 Apr 2026
Not a routine supplement — not recommended for self-directed use.
Information here is educational only, not a recommendation to use. See our Safety page.
Verify this peptide on CertiPep
certipep.ch — anonymous purity & characterization service
Evidence is from research or clinical settings — does not imply safety outside supervised contexts.
The evidence for oxytocin's effectiveness is moderate for improving social interactions and face processing in autistic children, but inconsistent for broader applications. Gaps remain in understanding its effects on restricted behaviors and the context-dependent nature of its benefits.
Restricted and repetitive behaviorsIndividuals with autism spectrum disorders · Meta-analysisLow
Oxytocin did not demonstrate significant benefit in reducing restricted and repetitive behaviors compared to placebo.
Social interaction improvementYoung children with autism · RCTModerate
Oxytocin nasal spray showed potential in improving social interactions in young children with autism.
Face expression processingAutistic children · RCTModerate
Chronic intranasal oxytocin administration improved face expression processing in autistic children.